Bristol Myers's $13 Billion Deal Is Hearty Indeed

Bookmark
(Bloomberg Opinion) -- Covid-19 is a major focus of health care these days, but the biggest pharmaceutical companies always seem to have time for M&A. On Monday, Bristol Myers Squibb & Co. said tha...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.